CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
 

BIIB's Capital Expenditures Growth by Quarter and Year

Biogen Inc 's Capital Expenditures results by quarter and year




BIIB Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 65.20 0.00 68.50 101.00
III Quarter September 87.60 59.10 43.90 84.10
II Quarter June 87.00 96.70 71.90 105.00
I Quarter March 71.60 57.90 92.60 186.70
FY   311.40 213.70 276.90 476.80



BIIB Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Biogen Inc in the fourth quarter 2023 achieved Capital Expenditures of $ 65.20 millions compare to Capital Expenditures recorded in same quarter a year ago.

Looking into fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Capital Expenditures growth. While Biogen Inc ' s Capital Expenditures no change of % ranks overall at the positon no. 560 in the fourth quarter 2023.




BIIB Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - -32.18 % -61.94 %
III Quarter September 48.22 % 34.62 % -47.8 % -6.66 %
II Quarter June -10.03 % 34.49 % -31.52 % -43.82 %
I Quarter March 23.66 % -37.47 % -50.4 % -56.29 %
FY   45.72 % -22.82 % -41.93 % -50.82 %

Financial Statements
Biogen Inc 's fourth quarter 2023 Capital Expenditures $ 65.20 millions BIIB's Income Statement
Biogen Inc 's fourth quarter 2022 Capital Expenditures $ 0.00 millions Quarterly BIIB's Income Statement
New: More BIIB's historic Capital Expenditures Growth >>


BIIB Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -25.57 % - 56.04 % 20.1 %
III Quarter September 0.69 % -38.88 % -38.94 % -19.9 %
II Quarter June 21.51 % 67.01 % -22.35 % -43.76 %
I Quarter March - -15.47 % -8.32 % -29.65 %
FY (Year on Year)   45.72 % -22.82 % -41.93 % -50.82 %




Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #64
Overall #560

Capital Expenditures Y/Y Growth Statistics
High Average Low
8828.42 % 274.36 % -82.61 %
(Sep. 30, 2016)   (Sep 30 2020)
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #64
Overall #560
Capital Expenditures Y/Y Growth Statistics
High Average Low
8828.42 % 274.36 % -82.61 %
(Sep. 30, 2016)   (Sep 30 2020)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biogen Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
4066.92 % 91.97 % -100 %
(Dec 31 2013)  


BIIB's IV. Quarter Q/Q Capital Expenditures Comment
In the IV. Quarter 2023 Biogen Inc disclosed fall in Capital Expenditures from the third quarter by -25.57% to $ 65.20 millions, from $ 87.60 millions released a quarter before.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Biogen Inc 's Capital Expenditures growth quarter on quarter, overall rank is 551.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #60
Overall #551
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #60
Overall #551
Capital Expenditures Q/Q Growth Statistics
High Average Low
4066.92 % 91.97 % -100 %
(Dec 31 2013)  


BIIB's IV. Quarter Q/Q Capital Expenditures Comment
In the IV. Quarter 2023 Biogen Inc realized fall in Capital Expenditures sequentially by -25.57% to $ 65.20 millions, from $ 87.60 millions released in the previous quarter.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Biogen Inc 's Capital Expenditures growth quarter on quarter, overall rank is 551.


Biogen Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 311.40 $ 0.00 $ 0.00 $ 0.00 $ 57.90
Y / Y Capital Expenditures Growth (TTM) - - - - -79.09 %
Year on Year Capital Expenditures Growth Overall Ranking # 560 # 1065 # 222 # 106 # 1658
Seqeuential Capital Expenditures Change (TTM) - - - - -79.48 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 560 # 820 # 1246 # 93 # 705




Cumulative Capital Expenditures growth Comment


In the Healthcare sector 63 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 560, from total ranking in previous quarter at 1065.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
8828.42 %
274.36 %
-82.61 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 64
Overall # 560

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
8828.42 %
274.36 %
-82.61 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 64
S&P 500 # 560
Cumulative Capital Expenditures growth Comment


In the Healthcare sector 63 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 560, from total ranking in previous quarter at 1065.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
8828.42 %
274.36 %
-82.61 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 64
Overall # 560

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
8828.42 %
274.36 %
-82.61 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 64
S&P 500 # 560




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BIIB's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BIIB's Competitors
Capital Expenditures Growth for Biogen Inc 's Suppliers
Capital Expenditures Growth for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Koru Medical Systems Inc-6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Conmed Corporation-14.46%$ -14.464 millions
Msa Safety Incorporated-14.60%$ -14.601 millions
Teva Pharmaceutical Industries Limited-16.20%$ -16.197 millions
Genedx Holdings Corp -16.28%$ -16.279 millions
Dexcom Inc -17.32%$ -17.323 millions
Davita Inc -17.74%$ -17.739 millions
Voyager Therapeutics Inc -19.08%$ -19.078 millions
Natera inc -19.40%$ -19.405 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com